Abbott Laboratories vs Misonix
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Abbott Laboratories is the larger company by market value: $181.1 B against $203 M for Misonix, 892 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 1, 2021 for Misonix). Misonix's value is the last on file, from Jan 1, 2021: no market-data feed is connected for its exchange yet.
- Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $62 M for Misonix in the year to December 2020.
- Abbott Laboratories made a net profit of $6.5 B, while Misonix made a net loss of $17 M.
- Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -27.9% for Misonix.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Abbott Laboratories ABT · #116 in the world | Misonix MSON |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Founded | 1888 | — |
| Size | ||
| Market cap | $181.1 B | $203 M* |
| Revenue | $44.3 B | $62 M |
| Net income | $6.5 B▲ best | $-17 M |
| Employees | 115,000 | — |
| Valuation | ||
| P/E ratio | 38.5× | — |
| Price to sales | 3.8× | — |
| Price to book | 3.5× | — |
| Free cash flow yield | 4.1% | — |
| Profitability | ||
| Gross margin | 56.4% | — |
| Operating margin | 18.2% | — |
| Net margin | 14.7% | — |
| Return on equity | 13.1% | — |
| Return on invested capital | 11.2% | — |
| Growth | ||
| Revenue growth | 5.7% | — |
| Revenue growth, 3 years a year | 0.5% | — |
| Earnings per share growth | -51.3% | — |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Cash | ||
| Free cash flow margin | 16.7% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.8% | — |
| Strength scores | ||
| Piotroski F-score | 6 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2021 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Abbott Laboratories or Misonix?
Abbott Laboratories is the larger company by market value: $181.1 B against $203 M for Misonix, 892 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 1, 2021 for Misonix). Misonix's value is the last on file, from Jan 1, 2021: no market-data feed is connected for its exchange yet.
Which makes more money, Abbott Laboratories or Misonix?
Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $62 M for Misonix in the year to December 2020. Abbott Laboratories made a net profit of $6.5 B, while Misonix made a net loss of $17 M.
Which is more profitable, Abbott Laboratories or Misonix?
Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -27.9% for Misonix.
More about Abbott Laboratories
More about Misonix
Sources#
Every figure on this page comes from these, with the date shown next to it.